Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases. Vallat J-M, Mathis S, Ghorab K, Milor M-A, Richard L, Magy L Eur Neurol. 2015 Apr 29; 73(5-6):294-302. Epub 2015 Apr 29. PMID: 25925430. Abstract CommentRecommendBookmarkWatch